Tocqueville Asset Management L.P. Acquires 7,238 Shares of Becton, Dickinson and Company $BDX

Key Points

• Tocqueville Asset Management L.P. increased its stake in Becton, Dickinson and Company by 6.9%, owning 112,230 shares worth approximately $25.71 million as of their latest SEC filing.
• Becton, Dickinson recently reported quarterly earnings of $3.68 per share, surpassing analysts' expectations, with revenue totaling approximately $5.51 billion.
• The company announced a quarterly dividend of $1.04 per share, yielding 2.1%, to be paid on September 30th, with the ex-dividend date set for September 8th.

Tocqueville Asset Management L.P. boosted its position in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 6.9% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 112,230 shares of the medical instruments supplier's stock after buying an additional 7,238 shares during the quarter. Tocqueville Asset Management L.P.'s holdings in Becton, Dickinson and Company were worth $25,708,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. Smallwood Wealth Investment Management LLC purchased a new stake in shares of Becton, Dickinson and Company during the first quarter valued at $27,000. REAP Financial Group LLC raised its stake in shares of Becton, Dickinson and Company by 75.3% during the 4th quarter. REAP Financial Group LLC now owns 128 shares of the medical instruments supplier's stock worth $29,000 after purchasing an additional 55 shares in the last quarter. Alpine Bank Wealth Management purchased a new stake in shares of Becton, Dickinson and Company during the 1st quarter worth about $29,000. Cornerstone Planning Group LLC raised its stake in shares of Becton, Dickinson and Company by 341.4% during the 1st quarter. Cornerstone Planning Group LLC now owns 128 shares of the medical instruments supplier's stock worth $29,000 after purchasing an additional 99 shares in the last quarter. Finally, Nexus Investment Management ULC acquired a new position in shares of Becton, Dickinson and Company during the 1st quarter valued at about $34,000. Institutional investors own 86.97% of the company's stock.

Becton, Dickinson and Company Trading Down 0.4%

NYSE:BDX traded down $0.7350 on Thursday, reaching $198.4650. The company's stock had a trading volume of 515,861 shares, compared to its average volume of 2,651,874. Becton, Dickinson and Company has a 1-year low of $163.33 and a 1-year high of $251.99. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.62 and a current ratio of 1.10. The firm has a market cap of $56.89 billion, a PE ratio of 35.70, a PEG ratio of 1.48 and a beta of 0.20. The business's 50-day moving average price is $179.66 and its two-hundred day moving average price is $196.25.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $3.68 earnings per share for the quarter, topping the consensus estimate of $3.40 by $0.28. Becton, Dickinson and Company had a return on equity of 16.23% and a net margin of 7.51%.The company had revenue of $5.51 billion during the quarter, compared to analysts' expectations of $5.50 billion. During the same period in the prior year, the firm earned $3.50 earnings per share. Becton, Dickinson and Company's revenue for the quarter was up 10.4% compared to the same quarter last year. Becton, Dickinson and Company has set its FY 2025 guidance at 14.300-14.450 EPS. Equities research analysts anticipate that Becton, Dickinson and Company will post 14.43 earnings per share for the current fiscal year.

Becton, Dickinson and Company Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Monday, September 8th will be paid a dividend of $1.04 per share. The ex-dividend date is Monday, September 8th. This represents a $4.16 dividend on an annualized basis and a dividend yield of 2.1%. Becton, Dickinson and Company's dividend payout ratio (DPR) is 74.82%.

Insider Transactions at Becton, Dickinson and Company

In other Becton, Dickinson and Company news, EVP Michael David Garrison sold 1,185 shares of the firm's stock in a transaction on Friday, July 18th. The stock was sold at an average price of $180.29, for a total transaction of $213,643.65. Following the transaction, the executive vice president owned 4,887 shares in the company, valued at $881,077.23. This trade represents a 19.52% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP David Shan sold 1,166 shares of the firm's stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $171.19, for a total value of $199,607.54. Following the completion of the sale, the executive vice president directly owned 4,575 shares in the company, valued at approximately $783,194.25. This represents a 20.31% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 3,214 shares of company stock worth $579,206. Company insiders own 0.36% of the company's stock.

Analysts Set New Price Targets

A number of research firms have issued reports on BDX. Raymond James Financial lowered Becton, Dickinson and Company from an "outperform" rating to a "market perform" rating in a report on Friday, May 2nd. Barclays lowered their target price on Becton, Dickinson and Company from $261.00 to $241.00 and set an "overweight" rating on the stock in a report on Tuesday, June 3rd. Wells Fargo & Company raised their target price on Becton, Dickinson and Company from $172.00 to $184.00 and gave the company an "equal weight" rating in a report on Friday, August 8th. William Blair lowered Becton, Dickinson and Company from an "outperform" rating to a "market perform" rating in a report on Thursday, May 1st. Finally, Bank of America lowered Becton, Dickinson and Company from a "buy" rating to a "neutral" rating and set a $190.00 price objective on the stock. in a report on Thursday, May 1st. Four equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $211.44.

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.